NO994908D0 - Nye 4-halogenerte steroider, fremstillingsmetode og mellomprodukter, anvendelse som medisin, og farmasöytiske preparater inneholdende disse - Google Patents

Nye 4-halogenerte steroider, fremstillingsmetode og mellomprodukter, anvendelse som medisin, og farmasöytiske preparater inneholdende disse

Info

Publication number
NO994908D0
NO994908D0 NO994908A NO994908A NO994908D0 NO 994908 D0 NO994908 D0 NO 994908D0 NO 994908 A NO994908 A NO 994908A NO 994908 A NO994908 A NO 994908A NO 994908 D0 NO994908 D0 NO 994908D0
Authority
NO
Norway
Prior art keywords
intermediates
medicine
preparation
new
pharmaceutical compositions
Prior art date
Application number
NO994908A
Other languages
English (en)
Other versions
NO315049B1 (no
NO994908L (no
Inventor
Yamina Bouali
Francois Nique
Jean-Georges Teutsch
Patrick Van De Velde
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO994908D0 publication Critical patent/NO994908D0/no
Publication of NO994908L publication Critical patent/NO994908L/no
Publication of NO315049B1 publication Critical patent/NO315049B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19994908A 1997-04-09 1999-10-08 Nye 4-halogenerte steroider, fremstillingsmetode og mellomprodukter, anvendelse og farmasöytiske preparater inneholdende disse NO315049B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704321A FR2761992B1 (fr) 1997-04-09 1997-04-09 Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
PCT/FR1998/000709 WO1998045316A1 (fr) 1997-04-09 1998-04-08 Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (3)

Publication Number Publication Date
NO994908D0 true NO994908D0 (no) 1999-10-08
NO994908L NO994908L (no) 1999-12-07
NO315049B1 NO315049B1 (no) 2003-06-30

Family

ID=9505672

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994908A NO315049B1 (no) 1997-04-09 1999-10-08 Nye 4-halogenerte steroider, fremstillingsmetode og mellomprodukter, anvendelse og farmasöytiske preparater inneholdende disse

Country Status (31)

Country Link
US (5) US6239121B1 (no)
EP (1) EP0973793B1 (no)
JP (1) JP4347420B2 (no)
KR (1) KR20010006149A (no)
CN (1) CN1259956A (no)
AP (1) AP1137A (no)
AR (1) AR012377A1 (no)
AT (1) ATE220408T1 (no)
AU (1) AU750030B2 (no)
BR (1) BR9809578A (no)
CA (1) CA2285679A1 (no)
DE (1) DE69806473T2 (no)
DK (1) DK0973793T3 (no)
EA (1) EA002116B1 (no)
ES (1) ES2178208T3 (no)
FR (1) FR2761992B1 (no)
HR (1) HRP980196B1 (no)
HU (1) HUP0002457A3 (no)
ID (1) ID22930A (no)
IL (1) IL132202A (no)
NO (1) NO315049B1 (no)
NZ (1) NZ337947A (no)
PL (1) PL190629B1 (no)
PT (1) PT973793E (no)
SK (1) SK284480B6 (no)
TR (1) TR199902507T2 (no)
TW (1) TW505621B (no)
UA (1) UA57073C2 (no)
WO (1) WO1998045316A1 (no)
YU (1) YU51199A (no)
ZA (1) ZA983046B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2780060B1 (fr) 1998-06-23 2000-08-04 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
FR2826004B1 (fr) 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
KR101129861B1 (ko) * 2006-12-29 2012-04-24 에프. 호프만-라 로슈 아게 아자스피로 유도체
US20120046461A1 (en) * 2009-01-23 2012-02-23 Northeastern University Steroidal anti-hormone hybrids
FR2942409B1 (fr) * 2009-02-20 2013-07-26 Natacha Voillot Composition pharmaceutique pour la prevention des avortements a repetition.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
US4676932A (en) * 1984-04-09 1987-06-30 The University Of New Mexico Synthesis of 1-haloestradiols
US4859585A (en) * 1986-04-17 1989-08-22 Trustees Of Tufts College In-vitro methods for identifying compositions which are agonists and antagonists of estrogens

Also Published As

Publication number Publication date
KR20010006149A (ko) 2001-01-26
SK136299A3 (en) 2000-05-16
TW505621B (en) 2002-10-11
AU750030B2 (en) 2002-07-11
TR199902507T2 (xx) 2000-07-21
CN1259956A (zh) 2000-07-12
AR012377A1 (es) 2000-10-18
US6462211B1 (en) 2002-10-08
EP0973793B1 (fr) 2002-07-10
EA199900909A1 (ru) 2000-04-24
JP2001518891A (ja) 2001-10-16
HRP980196B1 (en) 2003-08-31
YU51199A (sh) 2002-09-19
BR9809578A (pt) 2000-07-04
PT973793E (pt) 2002-11-29
US20020040135A1 (en) 2002-04-04
EA002116B1 (ru) 2001-12-24
ID22930A (id) 1999-12-16
PL336116A1 (en) 2000-06-05
NO315049B1 (no) 2003-06-30
US6399766B2 (en) 2002-06-04
IL132202A0 (en) 2001-03-19
IL132202A (en) 2004-02-19
DE69806473T2 (de) 2003-02-13
NZ337947A (en) 2001-04-27
EP0973793A1 (fr) 2000-01-26
ATE220408T1 (de) 2002-07-15
US6472382B2 (en) 2002-10-29
DK0973793T3 (da) 2002-10-28
SK284480B6 (sk) 2005-04-01
HUP0002457A3 (en) 2002-07-29
US20010008941A1 (en) 2001-07-19
CA2285679A1 (fr) 1998-10-15
HRP980196A2 (en) 1998-12-31
ES2178208T3 (es) 2002-12-16
JP4347420B2 (ja) 2009-10-21
PL190629B1 (pl) 2005-12-30
WO1998045316A1 (fr) 1998-10-15
DE69806473D1 (de) 2002-08-14
AP9901656A0 (en) 1999-09-30
ZA983046B (en) 1999-04-09
US6239121B1 (en) 2001-05-29
US20010039268A1 (en) 2001-11-08
FR2761992A1 (fr) 1998-10-16
UA57073C2 (uk) 2003-06-16
AP1137A (en) 2003-01-12
NO994908L (no) 1999-12-07
HUP0002457A1 (hu) 2001-02-28
US20010005756A1 (en) 2001-06-28
FR2761992B1 (fr) 1999-06-11
AU7339698A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
NO996433D0 (no) Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav
NO20002835L (no) 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor
DK1006110T3 (da) Derivater af acylpiperazinylpyrimidiner, fremstilling deraf og anvendelse som lægemidler
EE04673B1 (et) Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid
NO994620D0 (no) Nye 2-(iminometyl)amino-fenyl-derivater, fremstilling, anvendelse som medisiner og farmasöytiske blandinger inneholdende disse
DK0885204T3 (da) Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser
NO983955D0 (no) Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler
EE04276B1 (et) Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
NO20012272L (no) Nye erythromycinderivater, fremstillingsmetode og anvendelse som medisiner
NO994908L (no) Nye 4-halogenerte steroider, fremstillingsmetode og mellomprodukter, anvendelse som medisin, og farmasöytiske preparater inneholdende disse
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
NO20015058D0 (no) Nye ribose-substituerte aromatiske amider, metode for fremstilling, og andvendelse derav som medikamenter
EE200100173A (et) 2-fenüülpüraan-4-ooni derivaadid, nende valmistamismeetod ja kasutamine, vaheühendite kasutamine jafarmatseutiline kompositsioon
NO20004638L (no) Hypnotisk <beta>- karbolinderivater, fremgangsmÕte til deres fremstilling og deres anvendelse som legemiddelprodukt
DK1165528T3 (da) Hidtil ukendte morpholinoderivater, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
DK0806949T3 (da) Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf
NO992859L (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter
NO20006573L (no) Nye 17-halogenerte 19-nor-steroider, metode og mellomprodukter for fremstilling av disse, anvendelse som medisiner og farmasöytiske preparater inneholdende disse
EE200300548A (et) Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
NO995905D0 (no) Nye fencyclidinderivater, fremgangsmåter for fremstilling og farmasöytiske blandinger som inneholder disse
NO963129L (no) Nye leukotrien-B4-derivater, fremgangsmåte for fremstilling derav og anvendelse derav som legemidler
NO991481L (no) Nye heteroaryloksyetylaminer, fremgangsmÕte for fremstilling av, anvendelse som medisin og farmas°ytiske blandinger inneholdende disse
NO962782D0 (no) Farmasöytiske formuleringer omfattende polytiourea, og metode for anvendelse derav
NO991482D0 (no) Nye fenoksyethylaminderivater, fremgangsmÕte for fremstilling, anvendelse som medisin og farmas°ytiske blandinger inneholdende disse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees